Recombinant Interferon Beta

BIOLOGICAL3 trials

Sponsors

Case Comprehensive Cancer Center, Fred Hutchinson Cancer Center

Conditions

Merkel Cell Polyomavirus InfectionRecurrent MelanomaRecurrent Merkel Cell CarcinomaStage IV MelanomaStage IV Merkel Cell CarcinomaStage IV Merkel Cell Carcinoma AJCC v7

Phase 1

Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma

TerminatedNCT01758458

Fred Hutchinson Cancer CenterRecurrent Merkel Cell Carcinoma, Stage IV Merkel Cell Carcinoma

Start: 2013-02-28End: 2016-05-31Updated: 2017-04-19

Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma

TerminatedNCT02584829

Fred Hutchinson Cancer CenterMerkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7

Start: 2015-11-06End: 2018-12-18Updated: 2022-03-22

Phase 2

Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma

CompletedNCT00085306

Case Comprehensive Cancer CenterRecurrent Melanoma, Stage IV Melanoma

Start: 2004-04-30End: 2007-10-31Updated: 2015-10-02

Related Papers

Augmentation of adoptive T-cell therapy for Merkel cell carcinoma with avelumab.

Journal of Clinical Oncology2017-05-2013 citations